Impact of Glycoprotein IIb/IIIa Inhibitors Use on Outcomes After Lower Extremity Endovascular Interventions From Nationwide Inpatient Sample (2006-2011).

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2016 Oct

filter terms:

Anticoagulant and antiplatelet medications are necessary in peripheral endovascular intervention, but a standardized approach has not yet been established. Glycoprotein IIb/IIIa inhibitor use in endovascular lower extremity interventions decreased overall amputation rates. Glycoprotein IIb/IIIa inhibitor use in endovascular lower extremity interventions increased postprocedural bleeding and complications requiring intervention. © 2016 Wiley Periodicals, Inc.

Citation

Angela Echeverria, Zvonimir Krajcer. Impact of Glycoprotein IIb/IIIa Inhibitors Use on Outcomes After Lower Extremity Endovascular Interventions From Nationwide Inpatient Sample (2006-2011). Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2016 Oct;88(4):616-617